Anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart disease in which the left coronary artery, instead of arising from the left aortic sinus, abnormally originates from the main pulmonary artery. This malformation results in a critical hemodynamic anomaly, especially after birth, when both pressure and oxygenation in the pulmonary artery decrease drastically, preventing adequate myocardial perfusion of the left ventricle.
ALCAPA syndrome accounts for approximately 0.25–0.5% of all congenital heart defects and, if not surgically corrected, has an infant mortality rate exceeding 90%. It is one of the leading causes of myocardial ischemia and myocardial infarction in the first months of life, and a potentially reversible cause of dilated cardiomyopathy in childhood. Rare late-presenting forms of ALCAPA may occur in adulthood, with subtler symptoms but a persistent risk of sudden cardiac death.
Early recognition and surgical correction are crucial for survival and recovery of myocardial function. Timely surgery can fully reverse functional damage, especially if performed before irreversible fibrosis develops.
ALCAPA is a congenital malformation resulting from an error in the embryological development of the coronary system. Normally, coronary arteries develop as outgrowths of the aortic sinuses of Valsalva. In ALCAPA, an anomaly in the resorption and canalization of the primitive vascular plexuses leads to the left coronary artery arising from the pulmonary trunk, causing a primary structural defect that is irreversible—thus representing a definite etiological cause.
No environmental or acquired causes are known to induce ALCAPA. However, its association with other complex congenital heart anomalies and the presence of rare familial cases have led to hypotheses suggesting a role for genetic factors and disturbances in mesenchymal development, which are still under investigation. So far, no preventable risk factors have been identified with direct evidence.
The hemodynamic pathogenesis of ALCAPA emerges in the neonatal period. In utero, pulmonary artery pressure is similar to aortic pressure, and blood is richly oxygenated via the placenta: coronary perfusion is therefore adequate even in the presence of the malformation. After birth, the drop in pulmonary vascular resistance and the resulting decline in pressure and oxygenation within the pulmonary trunk cause blood to flow retrograde from the left coronary artery toward the low-pressure pulmonary artery, leading to a “coronary steal” phenomenon.
This results in severe hypoperfusion of the left coronary territory, which includes the majority of the left ventricular myocardium and the interventricular septum. The consequence is acute myocardial ischemia, contractile dysfunction, segmental hypokinesia, and dilated cardiomyopathy. In severe cases, a massive myocardial infarction may occur within the first weeks of life.
To compensate for the perfusion deficit, collateral vessels develop between the right coronary artery (which normally originates from the aorta) and the left coronary artery. However, flow through these collaterals is often insufficient or paradoxical (anterograde in diastole and retrograde in systole), potentially worsening the coronary steal and contributing to right coronary system congestion. Moreover, neurohormonal activation in response to hypoperfusion promotes salt and water retention, increased peripheral resistance, and worsening heart failure.
The long-term pathophysiology of uncorrected ALCAPA is characterized by progressive ventricular remodeling, atrial enlargement, elevated left ventricular end-diastolic pressure, development of functional mitral regurgitation, and a high risk of malignant ventricular arrhythmias. In some cases, a chronic form of partial adaptation may be observed in patients who survive the acute phase, but the risk of sudden death due to ischemia or arrhythmias remains high in the absence of anatomical correction.
The clinical presentation of ALCAPA depends on the age at onset, the extent of developed collateral coronary flow, and the degree of coronary steal toward the pulmonary artery. In the classic infantile form, symptoms emerge within the first 2–3 months of life, when pulmonary artery pressure decreases and left coronary perfusion becomes critically insufficient. The adult form, which is much rarer, appears during adolescence or adulthood in individuals who survived infancy thanks to a robust collateral system.
History taking should explore subtle but characteristic symptoms, often initially misinterpreted as gastroesophageal reflux or infant colic. In particular, feeding difficulties, inconsolable crying after feeding, and profuse sweating are signs of cardiac stress. The clinical history may include episodes of respiratory distress, hypotonia, and transient respiratory arrest, which should prompt suspicion of a cardiac origin.
The most frequent signs and symptoms in the infantile form include:
On physical examination, the following findings may be present:
In patients who survive the neonatal period due to a well-developed collateral network, ALCAPA may remain subclinical until adolescence or adulthood. In these cases, symptoms may include:
It is essential to maintain a high index of clinical suspicion in infants with idiopathic dilated cardiomyopathy, as approximately 10–15% of cases are ultimately found to have an anomalous coronary origin underlying the clinical picture.
The diagnosis of anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) requires a high index of clinical suspicion, particularly in infants with early-onset heart failure, cardiomegaly, and mitral regurgitation with no other clear etiology. Diagnostic delays or errors in such cases may be fatal. Definitive diagnosis is based on direct visualization of the anomalous coronary origin using advanced cardiac imaging.
Transthoracic echocardiography (TTE) is the first-line test and may reveal several suggestive findings:
When echocardiography is inconclusive or does not provide adequate assessment of the coronary origin, advanced imaging is indicated:
Coronary angiography, performed via cardiac catheterization, remains the reference standard for definitive anatomical confirmation, though it is reserved for ambiguous cases or when invasive hemodynamic assessment is required. It may reveal:
Electrocardiography (ECG) in infants often shows signs of anterior myocardial infarction (pathological Q waves in leads I, aVL, and V4–V6), even in the absence of chest pain. In older patients, ST-segment abnormalities, T-wave inversions, or ventricular arrhythmias may be observed.
The chest X-ray may demonstrate significant cardiomegaly with pulmonary congestion but lacks specificity.
In cases of severe heart failure, additional tests may include:
In summary, ALCAPA diagnosis relies on anatomical confirmation of the anomalous origin of the left coronary artery from the pulmonary trunk, along with functional signs of myocardial ischemia and heart failure. Echocardiography is the essential initial tool, but in most cases, it must be supplemented by CT angiography or MRI for accurate surgical planning.
The treatment of ALCAPA is exclusively surgical and should be performed as soon as possible after diagnosis, even in asymptomatic patients. The rationale is to restore antegrade coronary flow from the aortic root to the left coronary artery, thereby eliminating blood steal into the pulmonary circulation and preventing myocardial ischemia. The primary goal is re-arterialization of the left coronary artery, which is critical for long-term survival.
The preferred surgical strategy in most cases is direct reimplantation of the left coronary artery into the aortic root. This involves dissecting the anomalous coronary ostium from the pulmonary trunk and anastomosing it directly to the aorta. It is the most physiological option and provides normal myocardial perfusion, yielding the best long-term outcomes.
Alternatively, in cases with unfavorable anatomy or excessive distance between the coronary ostium and the aorta, different techniques may be used:
In the preoperative period, in the presence of severe left ventricular dysfunction or acute heart failure, stabilization is required with:
In neonates with severe ischemia and refractory hemodynamic instability, temporary mechanical support with ECMO (extracorporeal membrane oxygenation) may be indicated, either as a bridge to surgery or in the early postoperative phase to support left ventricular recovery.
In the postoperative period, management includes:
The prognosis of ALCAPA is closely linked to the timeliness of treatment. Without surgical correction, survival beyond infancy is extremely rare: 90% of untreated patients die within the first year of life. Early intervention, by contrast, leads to a marked improvement in clinical outcomes, with progressive recovery of ventricular function and regression of mitral regurgitation.
In neonates undergoing early surgery, long-term survival exceeds 95%, with favorable functional outcomes and satisfactory quality of life. Left ventricular function significantly improves within 3–6 months postoperatively, thanks to myocardial remodeling and restored coronary perfusion. Mitral regurgitation also spontaneously improves in most cases, without the need for valve surgery.
In patients treated at older ages, the prognosis remains favorable, although there is a higher risk of residual ventricular dysfunction, ventricular arrhythmias, and sudden death, particularly if extensive myocardial fibrosis is already present at diagnosis. In these patients, long-term follow-up with imaging and electrocardiographic monitoring is essential.
The risk of stenosis of the tunnel or new coronary anastomosis requires angiographic or CT surveillance in the months and years following surgery. In rare cases, reoperation or percutaneous revascularization may be necessary.
The main complications of untreated ALCAPA stem from insufficient oxygenated blood supply to the left ventricular myocardium. Clinical consequences may be devastating within the first weeks of life, but even adolescents or adults who survive due to collaterals may experience major adverse events.
Key complications include:
In surgically treated patients, the most frequent complications occur in the early postoperative period (transient arrhythmias, need for inotropic or ECMO support) and during residual cardiac remodeling. Persistent mitral regurgitation may occasionally require delayed surgical correction.
A thorough multidisciplinary follow-up (cardiology, pediatric cardiology, electrophysiology) is essential to prevent or manage long-term complications and ensure good quality of life in survivors.